SCHEMBL8868909

SCHEMBL8868909

O=C(O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)C3CCCCC3)cc2)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
TSHR P16473 2/20 0.53
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
HTR1A P08908 1/20 0.53
CYP2C9 P11712 1/20 0.53
NFKB1 P19838 1/20 0.53
CNR1 P21554 1/20 0.53
CYP2C19 P33261 1/20 0.53
ADRA1A P35348 1/20 0.53
BLM P54132 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
P4HTM Q9NXG6 3/20 0.44
USP5 P45974 2/20 0.42
POLB P06746 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 1/20 0.41
PPARG P37231 2/20 0.40
ALDH1A1 P00352 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869573 0.91 MAPT (0.56) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL9140536 0.91 P4HTM (0.55) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL8867649 0.91 MAPT (0.53) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL8868512 0.88 MAPT (0.47) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL8869656 0.88 MAPT (0.56) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL8868281 0.88 LMNA (0.49) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL8869180 0.88 TSHR (0.50) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL9141318 0.87 MAPT (0.54) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL8868905 0.86 MAPT (0.53) MAPTTSHRLMNACYP3A4HTR1A
SCHEMBL9137083 0.84 TSHR (0.51) MAPTTSHRLMNACYP3A4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed